Zhongguancun Technology Trade Fair seals deals across sectors

The 2024 Zhongguancun International Technology Trade Fair opens in Beijing on Thursday. [Photo provided to chinadaily.com.cn] Eleven deals were signed at the opening ceremony of the 2024 Zhongguancun International Technology Trade Fair in Beijing on Thursday, marking a fruitful start to the global technology trading event. Of them, four technology transfer contracts were inked between … Continue reading Zhongguancun Technology Trade Fair seals deals across sectors

InnoCare Pharma Limited expects multiple drug products to reach approval

The logo of InnoCare Pharma Limited. [Photo/VCG] InnoCare Pharma Limited, a Hong Kong-listed Chinese biopharma company, said that at least five of the company’s innovative drug products are expected to get approved and enter the market in three to four years. Also, up to four of such new drug products will enter the international market, … Continue reading InnoCare Pharma Limited expects multiple drug products to reach approval

BeiGene eyes imminent production in Guangzhou

BeiGene’s booth is seen during an expo in Beijing in September. [LI HE/FOR CHINA DAILY] BeiGene Ltd, a global oncology company, announced on Monday the completion of its antibody-drug conjugate production facility in Guangzhou, capital of Guangdong province, demonstrating its commitment to the industrialization of innovative medicines. The launch of the ADC facility marks a … Continue reading BeiGene eyes imminent production in Guangzhou

Sino Biopharm and Boehringer Ingelheim enter into strategic collaboration

Sino Biopharmaceutical Limited and Boehringer Ingelheim announce on Monday that they have entered into a strategic partnership. [Photo provided to chinadaily.com.cn] Sino Biopharmaceutical Limited, or Sino Biopharm, a China-based Hang Seng Index company, and Boehringer Ingelheim, a global biopharmaceutical company, announced on Monday that they had entered into a strategic partnership focusing on bringing innovative … Continue reading Sino Biopharm and Boehringer Ingelheim enter into strategic collaboration

Sino Biopharm shows stable growth in 2023

Sino Biopharmaceutical Limited. [Photo/Sino Biopharm website] Sino Biopharmaceutical Limited, or Sino Biopharm, a leading innovative research and development-driven pharmaceutical conglomerate in China, announced on Thursday in its annual result report that revenues from innovative drugs reached 9.89 billion yuan ($1.37 billion) in the 2023 fiscal year, up 13.3 percent year-on-year. Despite a challenging environment last year, … Continue reading Sino Biopharm shows stable growth in 2023

Pharma perfect match for China’s new forces

Takeda Pharmaceutical’s booth at the fifth CIIE. [Photo/VCG] Acknowledging China’s vision of cultivating new quality productive forces, Takeda Pharmaceutical Co Ltd remains upbeat about the Chinese market, aiming to further invest in the country, said its top executive. Christophe Weber, CEO of Takeda, said that China’s pursuit of new quality productive forces, which features innovation … Continue reading Pharma perfect match for China’s new forces